Inactive Instrument
Company Constellation Pharmaceuticals, Inc.
Stocks
CNST
US2103731061
Biotechnology & Medical Research
Business description: Constellation Pharmaceuticals, Inc.
Number of employees: 154
Sales by Activity: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Geographical breakdown of sales: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Executive Committee: Constellation Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | - |
Kia Khalaghpour
IRC | Investor Relations Contact | - | - |
Irina Apostolou
PRN | Corporate Officer/Principal | - | 31/07/2016 |
Brenda J. Sousa
COO | Chief Operating Officer | 62 | 31/03/2017 |
Composition of the Board of Directors: Constellation Pharmaceuticals, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 14/07/2021 | |
John McKenna
BRD | Director/Board Member | - | - |
Company details: Constellation Pharmaceuticals, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +2.74% | +38.10% | +74.02% | 56.54B | |
| -1.93% | -6.51% | +25.66% | +62.29% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -13.72% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +352.92% | 21.37B | |
| +0.15% | +0.36% | +24.28% | -14.44% | 20.27B | |
| +0.30% | -2.28% | +31.86% | -29.13% | 17.56B | |
| -1.45% | -7.15% | +17.96% | +554.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +287.77% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +160.72% | 13.33B | |
| Average | -0.14% | -3.79% | +35.34% | +159.44% | 25.98B | |
| Weighted average by Cap. | +0.02% | -2.96% | +30.18% | +120.42% |
